Leucid_Bio

#Biotech company pioneering next-generation CAR-T #celltherapies for hard-to-treat #cancers

Thinking laterally about #CART

[Leucid_Bio @Leucidbio]

🚨NEWS ALERT: The 2026 The @medicine_maker Power List is now live!

🎉Congratulation to our Founder and CSO, John Maher, who has been named an honouree in this year’s #PowerList - marking his third appearance on the list.
Check out the 2026 Power List: https://t.co/swiwBUxVcw

[Leucid_Bio @Leucidbio]

📰Leucid Bio featured in PharmaSource

In the latest insight piece from @ThePharmaSource, our CSO John Maher outlines key areas every biotech leader should assess before choosing a CDMO partner. To learn more, read the full article below. 👇

https://t.co/HKVcSQCfIC

[Leucid_Bio @Leucidbio]

📢 Leucid Bio CSO John Maher to present at Advanced Therapies UK

Check out details for John’s presentation at @AdTherapiesConf here➡️https://t.co/FeZIcm49s8

#adtherapies #AdvancedTherapiesCongress #CarTCellTherapy #CellTherapy

[Leucid_Bio @Leucidbio]

🌏International @womensday (#IWD)

@Leucidbio is proud to work alongside incredible women who are powering our mission. With their commitment, we remain focussed and dedicated to developing next generation CAR-T therapies.

#InternationalWomensDay #IWD2026 #CARTcellTherapy

[Leucid_Bio @Leucidbio]

🛫Are you heading to the IO360° Summit this week?

Be sure to catch our CEO @filpetti’s presentation at the #IO360Summit. See details here👉https://t.co/BZJv0VgQLO

@ConferenceForum @LifeSciEvents #CARTcellTherapy #celltherapy

[Leucid_Bio @Leucidbio]

Today is #WorldCancerDay, and at @Leucidbio we are proud to support the ongoing campaign #UnitedbyUnique.

📲Follow us on LinkedIn for the latest updates on our Phase I/IIa AERIAL trial of #LEU011

#CARTcellTherapy #celltherapy

[Leucid_Bio @Leucidbio]

📍@Leucidbio will be in San Francisco next week for the 44th @jpmorgan Healthcare Conference, 12-15 Jan.

🤝🏼Connect with our team onsite to learn more about Leucid's clinical-stage lead asset, #LEU011, a lateral NKG2D CAR-T.

#JPM2026 #JPMHealthcareConference #CARTcellTherapy

[Leucid_Bio @Leucidbio]

❄️ Season’s greetings!
With 2026 fast approaching, we take a moment to reflect on what a remarkable year 2025 has been for @Leucidbio, as we transitioned into the clinic with our lead asset #LEU011. See what else we achieved in 2025 here👉 https://t.co/Xp1xiw0sNe
#celltherapy

[Leucid_Bio @Leucidbio]

🚨Breaking news

🤝🏼@Leucidbio enters into a strategic collaboration with @Syenex

#Syenex will provide access to its #VivoCellPlatform to unlock the full potential of our lateral CAR-T pipeline, including #LEU011.

Read more: https://t.co/GkgyWDMV0T

#invivoCART #CARTcellTherapy

[Leucid_Bio @Leucidbio]

📰 Leucid Bio provides update on ongoing AERIAL #Clinicaltrial

Proof-of-concept established for lead asset #LEU011 in the treatment of relapsed/refractory solid tumours.

Read the press release here:

#CARTcellTherapies #CellTherapy

[Leucid_Bio @Leucidbio]

🚨Leucid Bio to present at Cell 2025 & PEGS Europe

Check out details on when and where to find the @Leucidbio team in action here➡️ https://t.co/rXZ5Rp7U2J

@OGConferences @PEGSboston @CHI_Healthtech

[Leucid_Bio @Leucidbio]

📅 Mark your calendars!

Our CEO @filpetti will present at #LSX #Investival Showcase.

Find out where to catch Filippo & our CFO Mark Docherty here👉https://t.co/gLSPtzp6uW

@LSXLeaders @InformaPLC #LLSW #celltherapy

[Leucid_Bio @Leucidbio]

🚨Leucid Bio featured in Medicine Maker

In @medicine_maker's latest eBook, our CSO John Maher reflects on his journey in the CAR-T space.

Check out the full interview on p14 of the Medicine Maker’s eBook📖here: https://t.co/6RhL4L1Y5W

#CARTcellTherapy #CellTherapy

[Leucid_Bio @Leucidbio]

🧬 As a pioneer in the field of #CARTcellTherapy, @Leucidbio's CSO John Maher will gave a virtual presentation at the upcoming Cell and Gene Therapy Symposium taking place from 10-11 October in Vellore, India.

See details here 👉https://t.co/BSfrFQO2gc

[Leucid_Bio @Leucidbio]

📅Save the Date!

Join @Leucid Bio at the upcoming @sitcancer 40th Annual Meeting taking place from November 7th-9th in National Harbor, MD.

Find out when and where to catch #LeucidBio's poster presentation👉https://t.co/Gz2uFG78xj

#SITC #SITC2025

[Leucid_Bio @Leucidbio]

💻ICYMI Leucid Bio featured in @DDWJournal webinar
ICYMI - our CSO John Maher was featured in the latest episode which explores the latest innovations in the #CGT space and the challenges the sector currently faces.

Watch the episode below⬇️

https://t.co/t8jdrW4nbB

[Leucid_Bio @Leucidbio]

Join our Senior Scientist Daniel Larcombe-Young at the @festofbiologics, presented in Basel where he will be presenting on @Lecudbio’s novel armoured Adaptor CAR T-cells for the treatment of solid #tumours on 30 Sept at 15.40 CEST!

@Terrapinn

[Leucid_Bio @Leucidbio]

ICYMI – Our CSO John Maher will be featured in an upcoming episode of @DDWJournal's podcast this Thursday.

Be sure to register and listen in as John shares his insights on the cell and gene therapy space – reserve your spot today⤵️

#CARTcellTherapy #drugdevelopment

[Drug Discovery World @DDWJournal]

Breaking barriers in cell and gene therapy

Thu, Sep 25, 2025 3:00 PM - 4:00 PM BST
Register for free now to secure your place at the webinar!
https://t.co/5kJdetF8LY

Sponsored by @oxfordnanopore
#GeneTherapy

[Leucid_Bio @Leucidbio]

🚨 Leucid Bio featured in @DDWJournal !🚨

Only 1️⃣week to go for the upcoming Cell & Gene Therapy episode of the DDW webinar series.

Check out details below on how to register and listen in👇

#CARTcellTherapy #drugdevelopment

[Drug Discovery World @DDWJournal]

Breaking barriers in cell and gene therapy

Thu, Sep 25, 2025 3:00 PM - 4:00 PM BST
Register for free now to secure your place at the webinar!
https://t.co/5kJdetF8LY

Sponsored by @oxfordnanopore
#GeneTherapy

[Leucid_Bio @Leucidbio]

🔺Today is Stand Up to Cancer Day🔺

Leucid Bio unites alongside @SU2C, a global initiative to raise awareness and fund research to detect and treat #cancers - the leading cause of deaths worldwide.

Check out the infographic below to see the global🌏impact of #cancer ⤵️

@SU2CUK